Inventor
SASU BARBRA JOHNSON
US25 patents
⚠️ This page may combine multiple inventors who share the name “SASU BARBRA JOHNSON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLOGENE THERAPEUTICS INC
13 patentsUS11673953B2Jun 13, 2023
DLL3 targeting chimeric antigen receptors and binding agents
ALLOGENE THERAPEUTICS INC9 citations81
US11072644B2Jul 27, 2021
Inhibitory chimeric antigen receptors
ALLOGENE THERAPEUTICS INC2 citations68
US12215347B2Feb 4, 2025
Chimeric antigen receptors with enhanced signaling and activities and uses thereof
ALLOGENE THERAPEUTICS INC0 citations61
US11781248B2Oct 10, 2023
Anti-TALEN antibodies and uses thereof
ALLOGENE THERAPEUTICS INC0 citations60
US12043655B2Jul 23, 2024
Constitutively active chimeric cytokine receptors
ALLOGENE THERAPEUTICS INC0 citations59
US11786553B2Oct 17, 2023
Chimeric cytokine receptors bearing a PD-1 ectodomain
ALLOGENE THERAPEUTICS INC0 citations59
US12447178B2Oct 21, 2025
Method of treatment using anti-CD19 rituximab-resistant chimeric antigen receptors
ALLOGENE THERAPEUTICS INC0 citations57
US12404315B2Sep 2, 2025
Protease-activating CD45-gate CAR
ALLOGENE THERAPEUTICS INC0 citations57
US11896617B2Feb 13, 2024
Polynucleotides encoding rituximab-resistant chimeric antigen receptors
ALLOGENE THERAPEUTICS INC0 citations57
US12528856B2Jan 20, 2026
Chimeric cytokine receptors comprising TGF β binding domains
ALLOGENE THERAPEUTICS INC0 citations56
US12036243B2Jul 16, 2024
BCMA CAR-T cells with enhanced activities
ALLOGENE THERAPEUTICS INC1 citations56
US12163153B2Dec 10, 2024
Methods of manufacturing allogeneic CAR T cells
ALLOGENE THERAPEUTICS INC0 citations54
US11732041B2Aug 22, 2023
Antibodies against 4G7-derived chimeric antigen receptors
ALLOGENE THERAPEUTICS INC0 citations50
PFIZER
11 patentsUS10294304B2May 21, 2019
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER16 citations93
US11377500B2Jul 5, 2022
Antibodies specific for CD70 and their uses
PFIZER8 citations83
US11312782B2Apr 26, 2022
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER1 citations71
US10259876B2Apr 16, 2019
Chimeric antigen receptors targeting epidermal growth factor receptor variant III
PFIZER3 citations68
US10221242B2Mar 5, 2019
Antibodies specific for epidermal growth factor receptor variant III and their uses
PFIZER4 citations68
US11396551B2Jul 26, 2022
Chimeric antigen receptors targeting CD70
PFIZER2 citations67
US11912776B2Feb 27, 2024
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER0 citations61
US11987634B2May 21, 2024
Antibodies specific for CD70 and their uses
PFIZER0 citations60
US11279764B2Mar 22, 2022
Antibodies specific for epidermal growth factor receptor variant III and their uses
PFIZER1 citations58
US11267892B2Mar 8, 2022
Chimeric antigen receptors targeting epidermal growth factor receptor variant III
PFIZER0 citations58
US12296012B2May 13, 2025
Chimeric antigen receptors targeting FLT3
PFIZER0 citations44